BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 22350877)

  • 1. Analysis of cellular SUMO and SUMO-ubiquitin hybrid conjugates.
    Schnellhardt M; Uzunova K; Bade VN; Krause A; Weisshaar SR; Praefcke GJ; Dohmen RJ
    Methods Mol Biol; 2012; 832():81-92. PubMed ID: 22350877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods to study SUMO dynamics in yeast.
    Pabst S; Döring LM; Petreska N; Dohmen RJ
    Methods Enzymol; 2019; 618():187-210. PubMed ID: 30850052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical characterization of SUMO-conjugating enzymes by in vitro sumoylation assays.
    Eisenhardt N; Ilic D; Nagamalleswari E; Pichler A
    Methods Enzymol; 2019; 618():167-185. PubMed ID: 30850051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconstitution of SUMO-dependent ubiquitylation in vitro.
    Keusekotten K; Praefcke GJ
    Methods Mol Biol; 2012; 832():111-23. PubMed ID: 22350879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIM-dependent enhancement of substrate-specific SUMOylation by a ubiquitin ligase in vitro.
    Parker JL; Ulrich HD
    Biochem J; 2014 Feb; 457(3):435-40. PubMed ID: 24224485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms in SUMO conjugation.
    Varejão N; Lascorz J; Li Y; Reverter D
    Biochem Soc Trans; 2020 Feb; 48(1):123-135. PubMed ID: 31872228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SUMO-Binding Entities (SUBEs) as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer.
    Lopitz-Otsoa F; Delgado TC; Lachiondo-Ortega S; Azkargorta M; Elortza F; Rodríguez MS; Martínez-Chantar ML
    J Vis Exp; 2019 Nov; (153):. PubMed ID: 31736480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SUMO: getting it on.
    Anckar J; Sistonen L
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1409-13. PubMed ID: 18031233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubc9 sumoylation controls SUMO chain formation and meiotic synapsis in Saccharomyces cerevisiae.
    Klug H; Xaver M; Chaugule VK; Koidl S; Mittler G; Klein F; Pichler A
    Mol Cell; 2013 Jun; 50(5):625-36. PubMed ID: 23644018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arkadia/RNF111 is a SUMO-targeted ubiquitin ligase with preference for substrates marked with SUMO1-capped SUMO2/3 chain.
    Sriramachandran AM; Meyer-Teschendorf K; Pabst S; Ulrich HD; Gehring NH; Hofmann K; Praefcke GJK; Dohmen RJ
    Nat Commun; 2019 Aug; 10(1):3678. PubMed ID: 31417085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUMO, Ubiquitin, UBL Proteins: Implications For Human Diseases - Fifth International Conference.
    Skaug B; Chen ZJ
    IDrugs; 2010 Apr; 13(4):224-7. PubMed ID: 20373248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fourier transform ion cyclotron resonance mass spectrometry for the analysis of small ubiquitin-like modifier (SUMO) modification: identification of lysines in RanBP2 and SUMO targeted for modification during the E3 autoSUMOylation reaction.
    Cooper HJ; Tatham MH; Jaffray E; Heath JK; Lam TT; Marshall AG; Hay RT
    Anal Chem; 2005 Oct; 77(19):6310-9. PubMed ID: 16194093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUMO-targeted ubiquitin ligases in genome stability.
    Prudden J; Pebernard S; Raffa G; Slavin DA; Perry JJ; Tainer JA; McGowan CH; Boddy MN
    EMBO J; 2007 Sep; 26(18):4089-101. PubMed ID: 17762865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sumoylation as a signal for polyubiquitylation and proteasomal degradation.
    Miteva M; Keusekotten K; Hofmann K; Praefcke GJ; Dohmen RJ
    Subcell Biochem; 2010; 54():195-214. PubMed ID: 21222284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome maintenance in Saccharomyces cerevisiae: the role of SUMO and SUMO-targeted ubiquitin ligases.
    Jalal D; Chalissery J; Hassan AH
    Nucleic Acids Res; 2017 Mar; 45(5):2242-2261. PubMed ID: 28115630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubc9 sumoylation regulates SUMO target discrimination.
    Knipscheer P; Flotho A; Klug H; Olsen JV; van Dijk WJ; Fish A; Johnson ES; Mann M; Sixma TK; Pichler A
    Mol Cell; 2008 Aug; 31(3):371-82. PubMed ID: 18691969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The small ubiquitin-like modifier (SUMO)-conjugating system of Toxoplasma gondii.
    Braun L; Cannella D; Pinheiro AM; Kieffer S; Belrhali H; Garin J; Hakimi MA
    Int J Parasitol; 2009 Jan; 39(1):81-90. PubMed ID: 18761012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMO-targeted ubiquitin ligases.
    Sriramachandran AM; Dohmen RJ
    Biochim Biophys Acta; 2014 Jan; 1843(1):75-85. PubMed ID: 24018209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin-dependent proteolytic control of SUMO conjugates.
    Uzunova K; Göttsche K; Miteva M; Weisshaar SR; Glanemann C; Schnellhardt M; Niessen M; Scheel H; Hofmann K; Johnson ES; Praefcke GJ; Dohmen RJ
    J Biol Chem; 2007 Nov; 282(47):34167-75. PubMed ID: 17728242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene.
    Wang CM; Brennan VC; Gutierrez NM; Wang X; Wang L; Yang WH
    J Cell Biochem; 2013 Mar; 114(3):589-98. PubMed ID: 22991139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.